Clinical Trials Directory

Trials / Completed

CompletedNCT00392145

Emergency Department Rapid Intravenous Rehydration (RIVR) for Pediatric Gastroenteritis

Emergency Department Rapid Intravenous Rehydration (RIVR) for Pediatric Gastroenteritis: A Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
226 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
90 Days – 18 Years
Healthy volunteers
Not accepted

Summary

This study will look at children with dehydration secondary to gastroenteritis requiring IV rehydration and determine whether the proportion rehydrated after two hours is greater in the children who receive rapid intravenous rehydration (RIVR) or in the children who receive standard IV rehydration.

Detailed description

Despite a movement toward increased use of enteral rehydration, many children still receive prolonged IV rehydration in the emergency department (ED). These children commonly receive a single IV bolus of normal saline followed by the administration of a hypotonic solution at a maintenance rate. The mean time spent in the ED by children receiving IV rehydration is significantly longer than the mean time required to treat all other conditions. ED overcrowding has been associated with poor outcomes, prolonged pain and suffering, and dissatisfaction. One of the solutions proposed in the American Academy of Pediatrics Policy Statement on ED overcrowding is that hospitals should strive to improve the efficiency of the care provided. One small step in this direction may be to improve our management of gastroenteritis and dehydration.

Conditions

Interventions

TypeNameDescription
DRUGStandard IV rehydrationA 20 mL/kg 0.9% normal saline bolus (maximum 999 mL) will be administered over 1 hour. This will be followed by D5-0.9% normal saline at a maintenance rate (maximum 55 mL/hr).
DRUGRapid intravenous rehydration (RIVR)A 60 mL/kg 0.9% normal saline bolus (maximum 999 mL) over 1 hour will be administered. This will be followed by D5-0.9% normal saline at a maintenance rate (maximum 55 mL/hr).

Timeline

Start date
2006-11-01
Primary completion
2010-05-01
Completion
2010-05-01
First posted
2006-10-25
Last updated
2018-04-17

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00392145. Inclusion in this directory is not an endorsement.